Medicare Enrolled

Dr. Jay Klarnet, MD

Medical Oncology · Oxnard, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1700 N ROSE AVE STE 470, Oxnard, CA 93030
8059887080
In practice since 2006 (19 years)
NPI: 1538258314 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Klarnet from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Klarnet? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Klarnet

Dr. Jay Klarnet is a medical oncology specialist in Oxnard, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Klarnet performed 2,152 Medicare services across 672 unique beneficiaries.

Between the years covered by Open Payments, Dr. Klarnet received a total of $7,742 from 58 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Klarnet is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in CA $7,742 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,152
Medicare services
Top 26% in CA for medical oncology
672
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
861 $128 $383
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
507 $0 $1
Anti-nausea injection (ondansetron/Zofran) 432 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $97 $273
New patient office visit, complex (60-74 min) 67 $156 $471
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
53 $1 $3
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
49 $95 $330
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
47 $22 $75
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
13 $134 $405
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.5% high complexity
46.1% medium
49.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,742
Total received (2018-2024)
Avg $1,106/year across 7 years
Top 40% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,221 (80.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$996 (12.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$525 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,264
2023
$1,753
2022
$1,306
2021
$1,341
2020
$749
2019
$615
2018
$713

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$173
Celgene Corporation
$170
SOBI, INC
$169
E.R. Squibb & Sons, L.L.C.
$71
GlaxoSmithKline, LLC.
$69
Bayer Healthcare Pharmaceuticals Inc.
$69
PFIZER INC.
$68
BeiGene USA, Inc.
$63
Daiichi Sankyo Inc.
$59
EMD Serono, Inc.
$55
AstraZeneca Pharmaceuticals LP
$53
Eisai Inc.
$41
PROGENICS PHARMACEUTICALS, INC.
$40
Astellas Pharma US Inc
$30
Karyopharm Therapeutics Inc.
$24
ABBVIE INC.
$22
Merck Sharp & Dohme LLC
$22
Genmab U.S., Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$16
Agios Pharmaceuticals, Inc.
$16
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$570
BeiGene, Ltd.
$525
Incyte Corporation
$455
Celgene Corporation
$381
Janssen Biotech, Inc.
$381
Novartis Pharmaceuticals Corporation
$337
Amgen Inc.
$318
SANOFI-AVENTIS U.S. LLC
$300
Seagen Inc.
$281
Astellas Pharma US Inc
$257
SOBI, INC
$251
AstraZeneca Pharmaceuticals LP
$222
Merck Sharp & Dohme Corporation
$217
Bayer Healthcare Pharmaceuticals Inc.
$214
Merck Sharp & Dohme LLC
$207
E.R. Squibb & Sons, L.L.C.
$192
BeiGene USA, Inc.
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
GlaxoSmithKline, LLC.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$142
Lilly USA, LLC
$140
GENZYME CORPORATION
$130
Ipsen Biopharmaceuticals, Inc
$103
AVEO Pharmaceuticals, Inc.
$102
EMD Serono, Inc.
$99
Bayer HealthCare Pharmaceuticals Inc.
$96
Kite Pharma, Inc.
$89
Myovant Sciences Inc.
$81
Pharmacyclics LLC, An AbbVie Company
$79
Sun Pharmaceutical Industries Inc.
$74
Eisai Inc.
$74
Tactile Systems Technology Inc
$72
Progenics Pharmaceuticals, Inc.
$65
Sobi, Inc
$64
Sumitomo Pharma America, Inc.
$61
Karyopharm Therapeutics Inc.
$61
Daiichi Sankyo Inc.
$59
Genmab U.S., Inc.
$52
Dova Pharmaceuticals
$48
Coherus Biosciences Inc.
$46
Gilead Sciences, Inc.
$46
Regeneron Healthcare Solutions, Inc.
$41
PROGENICS PHARMACEUTICALS, INC.
$40
JAZZ PHARMACEUTICALS INC.
$36
Pharmacyclics LLC, an AbbVie Company
$35
ABBVIE INC.
$22
EISAI INC.
$21
Roche Diagnostics Corporation
$17
Lexicon Pharmaceuticals, Inc.
$17
Genentech USA, Inc.
$17
Siemens Medical Solutions USA, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Agios Pharmaceuticals, Inc.
$16
Myriad Genetic Laboratories, Inc.
$15
Digestive Care, Inc.
$14
TESARO, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
Spectrum Pharmaceuticals Inc.
$12
Top 3 companies account for 20.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · BAVENCIO · BOSULIF · BRUKINSA · BYNFEZIA PEN · Bavencio · Beleodaq · Blincyto · CYRAMZA · DARZALEX · DIS Navify Software · DOPTELET · Doptelet · ELITEK · Enhertu · Erleada · FERAHEME · FLEXITOUCH · FOTIVDA · Flexitouch Plus · GILOTRIF · HYQVIA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MVASI · NINLARO · Neulasta · Nplate · Nubeqa · OFEV · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pertzye · Pomalyst · Prolaris · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · System SOMATOM Confidence · TABRECTA · TASIGNA · TECVAYLI · TUKYSA · Tivdak · Trodelvy · Udenyca · VERZENIO · Vitrakvi · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology specialist in Oxnard?
Compare medical oncologists in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
10
Per 100K population
1.2
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Klarnet is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Klarnet experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Klarnet performed 861 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Klarnet receive payments from pharmaceutical companies?
Yes. Dr. Klarnet received a total of $7,742 from 58 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Klarnet's costs compare to other medical oncologists in Oxnard?
Dr. Klarnet's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Klarnet) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →